Trip.com (TCOM) told investors it was a leading global one-stop travel service provider and the go-to destination for travelers in Asia, with a growing global reach. Expanding reach. Big ambitions. But investors say the regulatory risk was far greater than disclosed.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
A federal lawsuit filed in March 2026 alleges that Trip.com Group Limited misled investors about the severity of regulatory risks tied to its market position in China, risks that allegedly materialized when Chinese authorities launched a formal antitrust investigation into the company.
Investors who purchased or otherwise acquired publicly traded Trip.com securities on the NASDAQ between April 30, 2024, and January 13, 2026, are at the center of this litigation. The complaint alleges that when news of the Chinese antitrust probe became public on January 14, 2026, Trip.com’s ADS price fell $12.90 per share, or approximately 17.05%, closing at $62.78 that day, and dropped a further $1.48 per ADS, or 2.35%, the following day to close at $61.30.
Investors who purchased shares during the class period and suffered losses may have legal claims worth exploring.
Trip.com Group Limited: A Global Travel Platform With Deep China Roots
Trip.com describes itself in its public filings as a leading global one-stop travel service provider, offering a comprehensive suite of travel products and services along with differentiated travel content. The company states that it leverages a one-stop-shop model, high-quality service, and advanced technology to expand its global reach. It describes itself as the primary destination for travelers in Asia and an increasingly popular platform for travelers worldwide. Trip.com is incorporated in the Cayman Islands with its principal place of business in Singapore, and its ADSs trade on the NASDAQ under the ticker symbol TCOM.
What the Lawsuit Alleges Trip.com Got Wrong About Antitrust Risk
The complaint centers on how Trip.com characterized its exposure to Chinese antitrust regulation in its annual filings with the Securities and Exchange Commission. Specifically, the plaintiff alleges that Trip.com’s risk disclosures framed antitrust enforcement as a hypothetical future possibility, using conditional language such as “could be adversely affected,” when the company allegedly faced a more concrete and present regulatory threat given its alleged monopolistic business activities and the Chinese government’s track record of vigorous antitrust enforcement. The complaint alleges that this framing materially understated the actual risk facing the company. The overall theory of the case is that investors were kept in the dark about the extent of Chinese regulators’ scrutiny of Trip.com’s market position, leaving them unable to properly assess the company’s regulatory exposure.
Investors who believe they may have been affected by these alleged misstatements are encouraged to look into their rights and potential eligibility to participate in this litigation.
What Company Executives Are Alleged to Have Certified
The complaint does not cite specific public statements by CEO Jane Jie Sun or CFO Cindy Xiaofan Wang beyond their official certifications attached to the company’s annual reports. Both defendants signed Sarbanes-Oxley certifications accompanying Trip.com’s 2023 Annual Report, filed on Form 20-F on April 29, 2024, attesting to the accuracy of financial reporting, the disclosure of any material changes to internal controls over financial reporting, and the disclosure of all fraud. They signed substantially similar certifications accompanying the 2024 Annual Report, filed on Form 20-F on April 11, 2025. The complaint alleges that these certifications were false or misleading to the extent that the underlying risk disclosures materially understated Trip.com’s regulatory exposure.
How the Alleged Truth Emerged
The alleged corrective disclosure came on January 14, 2026, when Bloomberg published an article titled “China Starts Antitrust Probe of Trip.com Ahead of Travel Peak.” According to the complaint, the article reported that China’s State Administration for Market Regulation had accused Trip.com of abusing its market position and engaging in monopolistic practices, and that Trip.com stated it would cooperate with the investigation. The complaint also notes that the Bloomberg article referenced prior regulatory activity, including a meeting in August 2025 where Guizhou’s market regulator summoned five online tourism platforms to discuss antitrust concerns, and a September 2025 incident in which the market regulator in Zhengzhou summoned Trip.com for alleged violations of rules against setting unfair restrictions on merchants’ transactions and prices. Following the publication of this news, Trip.com’s ADS price fell $12.90 per share, or 17.05%, on January 14, 2026, and a further $1.48 per ADS, or 2.35%, on January 15, 2026.
Why Shareholders Who Traded During the Class Period Should Take Note
The complaint alleges that Trip.com’s annual risk disclosures gave investors an incomplete picture of the company’s actual regulatory situation in China. Investors who purchased TCOM ADSs between April 30, 2024, and January 13, 2026, based in part on these disclosures, may have paid prices that did not reflect the full scope of the antitrust scrutiny allegedly already developing. When that scrutiny became public through the Bloomberg report, the complaint alleges the market adjusted sharply downward, causing measurable losses for shareholders who had relied on the company’s prior disclosures.
The Legal Framework Behind the Claims
The complaint asserts violations of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, which together prohibit materially false or misleading statements in connection with the purchase or sale of securities. The plaintiff also asserts claims under Section 20(a) of the Exchange Act against CEO Jane Jie Sun and CFO Cindy Xiaofan Wang as controlling persons who allegedly exercised authority over the company’s disclosures during the class period. The central contention is that Trip.com’s risk disclosures falsely framed an active and foreseeable regulatory threat as speculative, depriving investors of information material to their investment decisions.
Investors who purchased Trip.com ADSs during the class period and wish to understand their legal rights are encouraged to consult with qualified securities counsel.
About Levi & Korsinsky, LLP
Levi & Korsinsky, LLP is a nationally recognized securities litigation firm representing investors in complex shareholder actions. The firm has extensive expertise and a team of over 70 employees to serve our clients. Attorney advertising. Prior results do not guarantee similar outcomes.
Disclaimer: This article is provided for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this article. Past results do not guarantee similar outcomes.